Nephrology Times

12/24/2025

🩺 Nephrologists: Speak up! Want to share your insight in a future “5 Nephrologists, 1 Question” feature? Send an email to charlotte[dot]robinson[at]formedics[dot]com.

12/23/2025

ICYMI: RUBY-3 demonstrates that targeting BAFF and APRIL with povetacicept can drive proteinuria reduction and immunologic remission in IgAN and pMN.

Povetacicept showed sustained proteinuria reduction and stable glomerular filtration rate at 48 weeks for patients with IgA nephropathy and primary membranous nephropathy.

12/22/2025

SPRINT data show intensive BP control favors most CKD patients, with greatest net benefit in those with lower eGFR.

Most patients with hypertension and chronic kidney disease (CKD) benefited from intensive BP lowering, especially those with more advanced CKD, an analysis of SPRINT data showed.

12/19/2025

ICYMI: 12-month VISIONARY results show sibeprenlimab sustains proteinuria reduction and remission in IgA nephropathy.

An interim analysis of VISIONARY data showed that sibeprenlimab sustains reductions in proteinuria and key disease biomarkers in patients with IgA nephropathy (IgAN) at 12 months.

12/18/2025

What should clinicians know about ADTKD? A recent review details disease subtypes, genetic testing, and practical management considerations.

A review described the clinical characteristics and subtypes of autosomal dominant tubulointerstitial kidney disease (ADTKD), a common monogenic cause of kidney failure.

12/17/2025

We spoke with Stefano Stuard, MD, PhD, about the clinical advantages of and its slow adoption in the US.

Following presentations on hemodiafiltration by Fresenius Medical Care at ASN Kidney Week 2025, Stefano Stuard, MD, PhD, discussed the therapy.

12/17/2025

John Gill, MD, spoke with us about the latest data on tegoprubart vs. tacrolimus for immunosuppression in kidney transplantation.

John Gill, MD, discussed phase 2 findings presented at ASN Kidney Week 2025 on tegoprubart for immunosuppression in kidney transplantation.

12/16/2025

In his column, Dr. Ajay Singh highlights the role of AI augmentation in electron microscopy of the kidneys.

In this editorial, Nephrology Times editor Dr. Ajay K. Singh highlights the role of artificial intelligence (AI) augmentation in electron microscopy of the kidneys.

12/15/2025

ICYMI: Joel Topf spoke with Vesna Garovic of Mayo Clinic at about pregnancy and hypertension, the topic of Dr. Garovic's inaugural Sharon Silbiger, MD, Endowed Lecture.

Joel Topf, MD, and Vesna Garovic, MD, PhD, discussed pregnancy and hypertension, the topic of her inaugural Sharon Silbiger, MD, Endowed Lecture at ASN Kidney Week 2025.

12/14/2025

Don't miss our Kidney Week coverage, including research news and interviews with researchers and presenters.

Review highlights from abstracts and presentations at ASN Kidney Week 2025, presented by the American Society of Nephrology, on Nephrology Times

12/13/2025

📖 🛋️ It's the weekend! Catch up on our latest issue, featuring the state of neph training, glom trial design, Kidney Week, and more. https://buff.ly/ukj5wIh